2018
Could overexpression of an ONCOGENE represent a good prognostic factor in cancer?
BENEŠ, Petr, Jan ŠMARDA a Lucia KNOPFOVÁZákladní údaje
Originální název
Could overexpression of an ONCOGENE represent a good prognostic factor in cancer?
Autoři
Vydání
XIX. setkání biochemiků a molekulárních biologů, 13.-14. 11. 2018, Brno, 2018
Další údaje
Typ výsledku
Konferenční abstrakt
Utajení
není předmětem státního či obchodního tajemství
ISBN
978-80-210-9069-9
Změněno: 29. 11. 2018 16:56, doc. Mgr. Petr Beneš, Ph.D.
Anotace
V originále
The c-Myb protein is a transcriptional regulator of stem cells maintenance in bone marrow, colon epithelia, and brain neurogenic niches. The pioneering research revealed that c-Myb is essential for normal hematopoiesis and identified it as important oncogene in various leukemias. The mechanism of its oncogenic function has been intensively studied in last decades and c-Myb is currently considered as a key regulator of balance between cell proliferation, differentiation and survival. Later studies found c-Myb overexpression in many carcinomas where its oncogenic function has been confirmed as well. Interestingly, we and others have recently shown that increased expression of c-Myb protein represents a good prognostic factor in breast and colon carcinomas. Our current research therefore aims to clarify this unusual phenomenon.
Návaznosti
GJ17-08985Y, projekt VaV |
| ||
NV18-07-00073, projekt VaV |
|